Personal information

Mexico

Activities

Employment (1)

Universidad Autónoma de Chiapas: Tuxtla, MX

2023-01-01 to present | Investigador (Centro de Investigación de Plantas Medicinales Chiapanecas, Laboratorio Experimental de Farmacología, Universidad Autónoma de Chiapas)
Employment
Source: Self-asserted source
Suárez Santiago José Eduardo

Education and qualifications (2)

Universidad de las Américas Puebla: Puebla, Puebla, MX

2011-06-04 to 2013-06-06 | Maestría en Psicología Clínica (Psicologia)
Education
Source: Self-asserted source
Suárez Santiago José Eduardo

Universidad del Valle de México - Campus Tuxtla Gutiérrez: Tuxtla Gutiérrez, Chiapas, MX

2007-06-03 to 2010-07-08 | Licenciado en Psicología (Psicología)
Education
Source: Self-asserted source
Suárez Santiago José Eduardo

Professional activities (1)

Consejo Nacional de Ciencia y Tecnología: Ciudad de México, MX

2019-01-01 | Miembro del Sistema Nacional de Investigadores
Distinction
Source: Self-asserted source
Suárez Santiago José Eduardo

Works (8)

Synergistic neuroprotective action of prolactin and 17β-estradiol on kainic acid-induced hippocampal injury and long-term memory deficit in ovariectomized rats

Hormones
2024-06 | Journal article
Part of ISSN: 1109-3099
Part of ISSN: 2520-8721
Contributors: Karen De la Torre; Marco Antonio Cerbón; Gladys Molina-Salinas; José Eduardo Suárez-Santiago; Jean-Pascal Morin; Gabriel Roldán-Roldán; OFIR PICAZO
Source: Self-asserted source
Suárez Santiago José Eduardo

The 5-HT6R agonist E-6837 and the antagonist SB-271046 reverse the psychotic-like behaviors induced by ketamine.

Behavioural pharmacology
2022-02-04 | Journal article
Source: Self-asserted source
Suárez Santiago José Eduardo

Repeated ketamine administration induces recognition memory impairment together with morphological changes in neurons from ventromedial prefrontal cortex, dorsal striatum, and hippocampus.

Behavioural pharmacology
2020-10-01 | Journal article
Source: Self-asserted source
Suárez Santiago José Eduardo

Magnolia officinalis Reduces Inflammation and Damage Induced by Recurrent Status Epilepticus in Immature Rats

Current Pharmaceutical Design
2020-05-06 | Journal article
Contributors: Angélica Vega-García; Luisa Rocha; Rosalinda Guevara-Guzmán; Christian Guerra-Araiza; Iris Feria-Romero; Juan M. Gallardo; Teresa Neri-Gomez; José E. Suárez-Santiago; Sandra Orozco-Suarez
Source: check_circle
Crossref

Agonist E-6837 and antagonist SB-271046 of 5-HT6 receptors both reverse the depressive-like effect induced in mice by subchronic ketamine administration.

Behavioural pharmacology
2017-10-01 | Journal article
Source: Self-asserted source
Suárez Santiago José Eduardo

Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease.

International journal of pharmaceutics
2016-11-30 | Journal article
Source: Self-asserted source
Suárez Santiago José Eduardo

Effect of ketamine administration, alone and in combination with E-6837, on climbing behavior.

Behavioural pharmacology
2016-08-01 | Journal article
Source: Self-asserted source
Suárez Santiago José Eduardo

Interacción de los receptores NMDA - 5-HT6 en la investigación preclínica de las alteraciones cognitivas relacionadas con la esquizofrenia

Psiquiatría Biológica
2015-01 | Journal article
Part of ISSN: 1134-5934
Source: Self-asserted source
Suárez Santiago José Eduardo